13F

MNKD MANNKIND CORP

2026Q1 · CUSIP 56400P706 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
250
Δ holders QoQ
-8
Breadth percentile
Top 83%
Whale holders
126
Δ whales
-4
Inst. holding value
$441M
New positions
47
Closed positions
55
Price momentum (1Q)
-46.0%
Put / Call
4/4

Breadth history (34 quarters)

2018Q1: Δ+5 · h=107 2018Q2: Δ+15 · h=122 2018Q3: Δ-5 · h=117 2018Q4: Δ+13 · h=130 2019Q1: Δ+5 · h=135 2019Q2: Δ-8 · h=127 2019Q3: Δ+1 · h=128 2019Q4: Δ+7 · h=135 2020Q1: Δ-10 · h=125 2020Q2: Δ+20 · h=145 2020Q3: Δ-5 · h=140 2020Q4: Δ+14 · h=154 2021Q1: Δ+8 · h=162 2021Q2: Δ+9 · h=171 2021Q3: Δ+9 · h=180 2021Q4: Δ+13 · h=193 2022Q1: Δ-13 · h=180 2022Q2: Δ+3 · h=183 2022Q3: Δ-8 · h=175 2022Q4: Δ+16 · h=191 2023Q1: Δ-4 · h=187 2023Q2: Δ-2 · h=185 2023Q3: Δ+10 · h=195 2023Q4: Δ+5 · h=200 2024Q1: Δ+2 · h=202 2024Q2: Δ+6 · h=208 2024Q3: Δ+21 · h=229 2024Q4: Δ+15 · h=244 2025Q1: Δ+13 · h=257 2025Q2: Δ-25 · h=232 2025Q3: Δ+0 · h=232 2025Q4: Δ+26 · h=258 2026Q1: Δ-8 · h=250 2018Q1: holders=107 2018Q2: holders=122 2018Q3: holders=117 2018Q4: holders=130 2019Q1: holders=135 2019Q2: holders=127 2019Q3: holders=128 2019Q4: holders=135 2020Q1: holders=125 2020Q2: holders=145 2020Q3: holders=140 2020Q4: holders=154 2021Q1: holders=162 2021Q2: holders=171 2021Q3: holders=180 2021Q4: holders=193 2022Q1: holders=180 2022Q2: holders=183 2022Q3: holders=175 2022Q4: holders=191 2023Q1: holders=187 2023Q2: holders=185 2023Q3: holders=195 2023Q4: holders=200 2024Q1: holders=202 2024Q2: holders=208 2024Q3: holders=229 2024Q4: holders=244 2025Q1: holders=257 2025Q2: holders=232 2025Q3: holders=232 2025Q4: holders=258 2026Q1: holders=250 -26 -13 +0 +13 +26 96184271 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 7 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 20% -46.0%
2025Q1 Top 19% -11.4% +11.4%
2024Q3 Top 16% -14.3% -37.2%
2023Q3 Top 18% +0.0% +30.6%
2020Q2 Top 17% +52.3% +213.1%
2018Q4 Top 18%
2018Q2 Top 16%

Options Sentiment

Put holders
4
QoQ: +2
Call holders
4
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.07
EPS YoY
-170.0%
Revenue (TTM)
$0.4B
Revenue YoY
+21.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $19M 2022-09-30: $33M 2022-12-31: $36M 2023-03-31: $41M 2023-06-30: $49M 2023-09-30: $51M 2023-12-31: $58M 2024-03-31: $66M 2024-06-30: $72M 2024-09-30: $70M 2024-12-31: $77M 2025-03-31: $78M 2025-06-30: $77M 2025-09-30: $82M 2025-12-31: $112M 2026-03-31: $90M 2022-06-30: EPS -0.11 2022-09-30: EPS -0.06 2022-12-31: EPS -0.07 2023-03-31: EPS -0.04 2023-06-30: EPS -0.02 2023-09-30: EPS 0.01 2023-12-31: EPS 0.01 2024-03-31: EPS 0.04 2024-06-30: EPS -0.01 2024-09-30: EPS 0.04 2024-12-31: EPS 0.03 2025-03-31: EPS 0.04 2025-06-30: EPS 0.00 2025-09-30: EPS 0.03 2025-12-31: EPS -0.05 2026-03-31: EPS -0.05 0M 56M 112M $M -0.12 -0.04 0.04 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 85 2024-03-31: PE 114.82024-06-30: PE 102.82024-09-30: PE 852024-12-31: PE 54.22025-03-31: PE 43.72025-06-30: PE 33.92025-09-30: PE 50.62025-12-31: PE 283 31 164 297 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)